# Phase II Study of Proton Radiation Therapy for Neuroblastoma

> **NCT02112617** · NA · RECRUITING · sponsor: **Massachusetts General Hospital** · enrollment: 30 (estimated)

## Conditions studied

- Neuroblastoma
- Ganglioneuroblastoma

## Interventions

- **RADIATION:** Proton Beam Radiation Therapy

## Key facts

- **NCT ID:** NCT02112617
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2014-06
- **Primary completion:** 2026-06-30
- **Final completion:** 2028-03
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-05-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02112617

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02112617, "Phase II Study of Proton Radiation Therapy for Neuroblastoma". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02112617. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*